Robert E. Hoffman is currently Chief Financial Officer and Senior Vice President of Heron Therapeutics. Prior to joining Heron, Mr. Hoffman served as Executive Vice President and Chief Financial Officer of Innovus Pharmaceuticals, Inc., since September 2016. Prior to Innovus, Mr. Hoffman was Chief Financial Officer of AnaptysBio, Inc. from July 2015 until September 2016. He was part of the founding management team of Arena Pharmaceuticals, Inc. in 1997, ultimately serving as Senior Vice President, Finance and Chief Financial Officer until March 2011, and then again from August 2011 until July 2015. From March 2011 to August 2011, he served as Chief Financial Officer for Polaris Group. Mr. Hoffman is a member of the board of directors of CombiMatrix Corporation, Kura Oncology, Inc., and MabVax Therapeutics Holdings, Inc. He also is a member of the Financial Accounting Standards Board’s Small Business Advisory Committee and is a member of the steering committee of the Association of Bioscience Financial Officers. Mr. Hoffman received his B.B.A. from St. Bonaventure University, and is licensed as a C.P.A. (inactive) in the State of California.
Robert E. Hoffman